Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
Frédéric B. Piel, David C. Rees, Michael R. DeBaun, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e633-e686
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)
Bradford L. Therrell, Carmencita D. Padilla, Gustavo Borrajo, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 2, pp. 38-38
Open Access | Times Cited: 31
Sickle Cell Disease Update: New Treatments and Challenging Nutritional Interventions
Victoria Bell, Theodoros Varzakas, Θεοδώρα Ψαλτοπούλου, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 258-258
Open Access | Times Cited: 14
Stroke Prevention in Hispanic Children with Sickle Cell Anemia: the SACRED trial
Rosa M. Nieves, Teresa S. Latham, Nicolle Marie Marte, et al.
Blood Advances (2025)
Open Access | Times Cited: 1
Strengthening global partnerships for sustainable sickle cell disease care: insights from SickleInAfrica at the 77th United Nations General Assembly and the US-Africa Leaders’ Summit
Irene Kida Minja, Siana Nkya, Daima Bukini, et al.
BMJ Global Health (2025) Vol. 10, Iss. 3, pp. e017154-e017154
Open Access | Times Cited: 1
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Valeria Maria Pinto, Filippo Mazzi, Lucia De Franceschi
Blood (2024) Vol. 144, Iss. 8, pp. 853-866
Open Access | Times Cited: 7
Global burden of sickle cell disease in 2021
Valentine Brousse, Baba Inusa, David C. Rees
The Lancet Haematology (2023) Vol. 10, Iss. 10, pp. e792-e792
Closed Access | Times Cited: 15
Successes and pitfalls in orphan drug development for sickle cell disease
Enrico Costa, Antonella Isgrò, Mariane de Montalembert, et al.
Blood Advances (2024) Vol. 8, Iss. 10, pp. 2455-2465
Open Access | Times Cited: 6
Iron restriction in sickle cell disease: When less is more
Oswaldo Castro, Lucia De Franceschi, Tomas Ganz, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 7, pp. 1349-1359
Open Access | Times Cited: 5
Managing gastrointestinal challenges: Diarrhea in sickle cell anemia
Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu
Medicine (2024) Vol. 103, Iss. 18, pp. e38075-e38075
Open Access | Times Cited: 5
Transfusions, disease-modifying treatments, and curative therapies for sickle cell anemia in Africa: where are we now?
Isaac Odame, Godwin Nosakhare Bazuaye
Hematology (2024) Vol. 2024, Iss. 1, pp. 234-239
Closed Access | Times Cited: 4
Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks
Bill Wambaka, Amiirah Mpungu, Vincent Mboizi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Use of hydroxyurea in French-speaking Sub-Saharan Africa
J Arlet, Françoise Bernaudin, Indou Dème-Ly, et al.
Annals of Hematology (2025)
Open Access
The novel SCD MED ALERT mHealth app: empowering patients with sickle cell disease
Simone Villaboni, Valeria Maria Pinto, Barbara Gianesin, et al.
Rare Disease and Orphan Drugs Journal (2025) Vol. 4, Iss. 1
Open Access
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
Arturo J Martí-Carvajal
Frontiers in Hematology (2025) Vol. 4
Open Access
The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries
Jeremy W. Jacobs, Luiz Amorim, France Pirenne, et al.
British Journal of Haematology (2025)
Open Access
Sickle cell care and implementation science
Halima Bello‐Manga, Allison A. King
Blood Advances (2025) Vol. 9, Iss. 8, pp. 1859-1860
Closed Access
“Learn and Know” in the era of gene addition/gene editing based approaches for sickle cell disease: The EHA-EBMT consensus paper
Lucia De Franceschi, Emanuele Angelucci
Bone Marrow Transplantation (2025)
Closed Access
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet
Pablo Velasco, Soteroula Christou, Saveria Campisi, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks
Bill Wambaka, Amiirah Mpungu, Vincent Mboizi, et al.
Pediatric Blood & Cancer (2025)
Closed Access
Innovations in Drug Discovery for Sickle Cell Disease Targeting Oxidative Stress and NRF2 Activation—A Short Review
Athena Starlard‐Davenport, Chithra D. Palani, Xingguo Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4192-4192
Open Access
Treating sickle cell disease in resource-limited sub-saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidenced based management
Miguel Brito, Catarina Ginete, Akinyemi O D Ofakunrin, et al.
Expert Review of Hematology (2025)
Closed Access
Sickle hemoglobinopathy research in Zimbabwe and Zambia: setting up an international sickle cell disease registry
Patience Kuona, Gwendoline Kandawasvika, Catherine Chunda‐Liyoka, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
An update review of new therapies in sickle cell disease: the prospects for drug combinations
Sanne Lugthart, Catarina Ginete, Patience Kuona, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 2, pp. 157-170
Closed Access | Times Cited: 3
Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review
Laura Drown, Miriam A. Osei, Ada Thapa, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 4, pp. e299-e308
Closed Access | Times Cited: 3
Emergency Presentations of Pediatric Sickle Cell Disease in French Guiana
Carine Fankep Djomo, Souam Nguele Silé, Narcisse Elenga
Diseases (2025) Vol. 13, Iss. 5, pp. 142-142
Open Access
Page 1 - Next Page

Scroll to top